Boehringer Ingelheim Achieves Perfect Score for 10th Time for Workplace Equality for the LGBTQ Community

Boehringer Ingelheim received a perfect score on the Corporate Equality Index (CEI) and has been designated as a 2018 Best Place to Work for LGBTQ Equality.
Author:
Publish date:
Social count:
51

Today marks the 10th time that Boehringer Ingelheim has received a perfect score on the Corporate Equality Index (CEI) and has been designated as a 2018 Best Place to Work for LGBTQ Equality. Administered by the Human Rights Campaign Foundation, the CEI is a national benchmarking report on corporate policies and practices related to workplace equality for lesbian, gay, bisexual, transgender and questioning/queer (LGBTQ) employees.

“Achieving a perfect score that recognizes our support of the LGBTQ community is a great sense of pride for our company and we are honored to be recognized yet again by the Human Rights Campaign,” said Nancy Di Dia, Executive Director Americas, Head, Office of Diversity, Inclusion & Engagement, Boehringer Ingelheim. “We are proud to support the LGBTQ community and are committed to fostering an environment of respect and inclusion that celebrates diversity of ideas, individuality, and personal experience, which we know contribute to our success in changing the lives of the patients we serve.”

The 2018 CEI rated 945 businesses in the report, which evaluates LGBTQ-related policies and practices including non-discrimination workplace protections, domestic partner benefits, transgender-inclusive health care benefits, competency programs and public engagement with the LGBTQ community. Boehringer Ingelheim has satisfied and exceeded all of the CEI’s criteria for a tenth time resulting in a 100 percent score. The company is among 609 major U.S. businesses that earned top marks this year.

Boehringer Ingelheim’s CEI perfect score follows other recent honors including Working Mother magazine’s 100 Best Companies and Science Magazine annual list of “top employers.”

For more information on the 2017 Corporate Equality Index, or to download a free copy of the report, visit www.hrc.org/cei.

Boehringer Ingelheim
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation.

Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with approximately 50,000 employees. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.

Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities. Please visit our website to learn more about how we make more health for more people through our Corporate Social Responsibility initiatives.

In 2016, Boehringer Ingelheim achieved net sales of about $17.6 billion (15.9 billion euros). R&D expenditure corresponds to 19.6 percent of its net sales.

For more information please visit www.boehringer-ingelheim.us, or follow us on Twitter @BoehringerUS.

About the Human Rights Campaign Foundation
The Human Rights Campaign Foundation is the educational arm of America's largest civil rights organization working to achieve equality for lesbian, gay, bisexual transgender and queer people. HRC envisions a world where LGBTQ people are embraced as full members of society at home, at work and in every community.